Mar 09, 2018 14:01 pm UTC| Business
NEW YORK, March 09, 2018 -- Nuxeo, the leading cloud-native Content Services Platform, today announced the company has been positioned by Aragon Research, Inc., a leading technology-focused research and advisory firm,...
II-VI Incorporated to Participate at the OIDA Executive Forum and Present at OFC
Mar 09, 2018 14:01 pm UTC| Business
PITTSBURGH, March 09, 2018 -- II‐VI Incorporated (NASDAQ:IIVI), a global leader in engineered materials and optical solutions for networks, today announced that Dr. Chuck Mattera, President and CEO, will participate at...
Flame Seal Products, Inc. Releases December 31, 2017 Fourth Quarter and Full Year Results
Mar 09, 2018 14:01 pm UTC| Business
Houston, Texas, March 09, 2018 -- FLAME SEAL PRODUCTS, INC. (OTC PINK: FLMP), a leading provider of Specialty Chemicals for the Passive Fire Protection Market, today issues the following update to its Stockholders. ...
Clover Health Discusses Behavioral Science at SXSW 2018
Mar 09, 2018 14:01 pm UTC| Business
SAN FRANCISCO, March 09, 2018 -- Clover Health, a health insurance company using data and technology to fill gaps in care and improve health outcomes, today announced its participation at the SXSW Interactive Festival...
Friday Night: Well Positioned in Nevada’s Growing Rec Market -- CFN Media
Mar 09, 2018 14:00 pm UTC| Business
SEATTLE, March 09, 2018 -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the fast start for Nevada’s...
Globus Maritime Limited Reports Financial Results for the Quarter and Year Ended December 31, 2017
Mar 09, 2018 14:00 pm UTC| Business
ATHENS, Greece, March 09, 2018 -- Globus Maritime Limited ("Globus," the “Company," “we,” or “our”) (NASDAQ:GLBS), a dry bulk shipping company, today reported its unaudited consolidated operating and financial results...
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
Mar 09, 2018 13:47 pm UTC| Business
Pipeline Achievements in 2017 Included Progress with Three Phase 3 and Two Phase 2 Clinical Trials -Key 2018 Clinical Milestones Anticipated for All Three Development Compounds Lead Compound OBE2109 Endometriosis...